(Q43970914)

28 November 2017

title

Effects of duodenal fat, protein or mixed-nutrient infusions on epigastric sensations during sustained gastric distension in healthy humans (English)

1 reference

28 November 2017

1 reference

Feinle C

1

1 reference

28 November 2017

Christen M

2

1 reference

28 November 2017

Grundy D

3

1 reference

28 November 2017

Faas H

4

1 reference

28 November 2017

Meier O

5

1 reference

28 November 2017

Otto B

6

1 reference

28 November 2017

Fried M

7

1 reference

28 November 2017

publication date

1 April 2002

1 reference

Neurogastroenterology and Motility

28 November 2017

published in

1 reference

28 November 2017

volume

14

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

205-213

1 reference

Gastrointestinal correlates of the development of hunger in man.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Attenuation of the anorectic effects of cholecystokinin and bombesin by the specific amylin antagonist AC 253.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

The cholecystokinin antagonist, proglumide, increases food intake in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Duodenal infusion of fat, cholecystokinin secretion and satiety in the pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Plasma concentrations of cholecystokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2982.2002.00318.X

10.1046/J.1365-2982.2002.00318.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference